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information on behavior of the pathogen distribution for all age groups and their 
changes over time and is thereby a real extension to classical static decision tree based 
methods in HTA. The used validated simulation system is dealing with transparent 
parameters and is better understandable for decision makers in HTA.
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OBJECTIVES: Antidepressants carry an increased risk of suicidality in children, 
adolescents and young adults. The primary aim was to determine antidepressant 
prescribing and cost to patients aged 18 years and younger in a South African private 
health care sector patient population. METHODS: A retrospective, cross-sectional 
pharmacoepidemiological study was undertaken on prescription data of a private 
pharmacy group in South Africa for 2009. The study focused on antidepressant pre-
scribing. No diagnoses were available. a total of 814540 antidepressants were pre-
scribed, of which 12549 were prescribed to patients aged 18 years or younger. 
RESULTS: A total of 4269 patients (53.74% females) received an average of 2.94 (SD 
= 3.31) antidepressants over the year. The total cost of antidepressant prescribing was 
R1 581480, with an average cost of R126.02 per product (item). Two-thirds (66.67%) 
of antidepressants were prescribed to patients from 12 to 18 years of age. Selective 
serotonin re-uptake inhibitors (SSRIs) accounted for 55.91% of antidepressant pre-
scribing, followed by tricyclic antidepressants (32.32%), together accounting for 
79.49% of antidepressant cost. Lithium was only prescribed to 1.04% of patients in 
this age group. The highest average cost was for serotonin and noradrenaline re-uptake 
inhibitors (R322.94 per product), selective mono-amine oxidase inhibitors (R177.20) 
and SSRIs (R155.52). Tablets were the preferred dosage form. The most frequently 
prescribed active ingredients were imipramine (19.77%), escitalopram (14.60%), 
citalopram (14.09%) and ﬂ uoxetine (13.92%), together accounting for 62.38% of 
prescribing frequency. CONCLUSIONS: Diagnoses were not available, therefore only 
prescribing trends could be investigated. Fluoxetine generally has a favourable risk-
beneﬁ t balance (prescribed “off label”), yet it only had a prescribing frequency of 
13.92% in this study. Active ingredients such as escitalopram and citalopram are not 
preferable in this age group. The risk of prescribing antidepressants in children, 
adolescents and young adults should be balanced against the clinical need.
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OBJECTIVES: There has been much controversy over the prescribing of selective 
serotonin re-uptake inhibitors (SSRIs) and selective serotonin and noradrenaline re-
uptake inhibitors (SNRIs) regarding their safety and efﬁ cacy in patients younger than 
19 years with limited guidelines to prescribers from South African authorities. The 
primary aim was to investigate the prescribing patterns of SSRIs and SNRIs to children 
and adolescents, younger than 19 years, in a primary practice setting in a South 
African patient population. METHODS: Data from 2009 of patients younger than 
19 years who were prescribed antidepressants belonging to a private medical aid 
scheme were retrospectively analyzed. RESULTS: There were 440 patients younger 
than 19 years receiving antidepressant drugs accounting for 6.20% of patients of any 
age receiving antidepressant therapy. SSRIs and SNRIs were prescribed to 50.68% of 
these patients. Female patients were prescribed SSRIs and SNRIs most frequently 
(62.33%). The average age of patients was 14.21 (SD = 3.05) years while the majority 
of patients were older than 12 years (77.13%). Fluoxetine was prescribed most fre-
quently (36.50%), followed by citalopram (22.14%) and escitalopram (17.15%). The 
total cost of SSRIs and SNRIs amounted to R81201.69. Escitalopram accounted for 
30.28% of the cost while ﬂ uoxetine only accounted for 11.11% of the cost. Venla-
faxine accounted for 6.32% of prescriptions although being contraindicated in this 
patient population. Paroxetine accounted for 5.96% of prescriptions although its use 
is not recommended due to possible suicidality side effects. a total of 72.65% of 
patients received drug therapy for less than 6 months while 41.26% of patients 
received a single prescription for an SSRI or SNRI. General practitioners prescribed 
67.76% of prescriptions while psychiatrists only prescribed 14.96%. CONCLU-
SIONS: The prescribing of these agents to children and adolescents needs to be further 
investigated using retrospective data which include clinical information and studies 
conducted over a longer time period.
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OBJECTIVES: Maternal mortality rate in India: a comprehensive literature review. 
METHODS: Information was retrieved from websites of World Health Organization, 
Pubmed and grey literature retrieved using key terms like maternal mortality, MMR 
etc. The relevant prevalence data were extracted and compiled. RESULTS: The mater-
nal mortality rate (MMR) is maternal death per 100,000 live births in one year. WHO 
estimates show that out of the 529,000 maternal deaths globally each year, 
136,000(25.7%) are contributed by India. According to registrar general of India 
estimates for the year 2000, MMR for India was 407/100,000 live births. The trend 
has not changed signiﬁ cantly in the last 5 years. In the Armed Forces the scenario is 
very encouraging with a MMR of 36 per 100,000 live births. In 1980, India reported 
about 677 maternal deaths per 1, 00,000 live births but in 2008, this was down to 
254 deaths. MMR has reduced by 4% a year since 1990. High MMR was reported 
in Hindu (573) than Muslims (384) and in Illiterate people (574) (1994). India has 
climbed from bottom to 127th place in the MMR ratings, above Pakistan and just 
below Nepal. Hemorrhage (25.6–38%) ranks ﬁ rst as the cause of maternal death, 
followed by anemia (14–24%) sepsis (13–16%), toxemia of pregnancy (11.9%), abor-
tions (8–9%) and obstructed labor (6.2–10%) while other causes together total 
35.3%. Tamil Nadu has taken initiatives to improve maternal health services leading 
to reduction in maternal mortality from 380 in 1993 to 90 in 2007 due to increased 
rate of institutional deliveries from 20% in 1971 to 97.7% in 2007. CONCLUSIONS: 
A consistent decline in the maternal mortality rate has been observed in India but it 
attributes to a few states. Initiatives need to be taken by government in regard to 
proper facility in hospitals, efﬁ cient supply of blood, and iron containing medicines.
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OBJECTIVES: The recent large increase in caesarean sections (CSs) in Europe seems 
not to be completely justiﬁ ed: CS is practiced independently of epidemiological evi-
dence. This work analyzes costs and beneﬁ ts effectively involved in alternative 
methods of delivery- vaginal delivery (VD), with and without epidural analgesia, and 
planned caesarean. METHODS: The empirical analysis has been conducted in an 
Italian University hospital, through direct collection of data, questionnaires and inter-
views to patients and staff. a logistic regression has been used to model the probability 
of the event “delivery with planned caesarean section” occurring as a function of a 
set of clinical and socio-economic characteristics of the women. a micro–costing 
analysis has been used to assess the direct health costs, following an activity–based 
costing approach. From a societal perspective we consider also the indirect and the 
intangible costs of each method. Patients’ wellbeing is measured through appropriate 
anonymous instruments—the State-Trait Anxiety Inventory, the Italian Questionnaire 
of Pain and the Childbirth Perception Questionnaire- to measure the changes in clinical 
and psychological dimensions due to the delivery experience. RESULTS: The results 
conﬁ rm the hypothesis that CS is widely performed for non-medical reasons (Osborn, 
1995). The analysis shows that CS is, on average, more expensive than VD, but the 
difference is marginal if we take into account the opportunity-cost of labour time. 
CONCLUSIONS: Since CS is generally reimbursed more than VD to cover the sup-
posed higher costs of surgery, differences between the real costs and the DRG tariffs 
may induce opportunistic behaviour in terms of clinical practice. We show that, in 
general, VD with analgesia provides better results both in terms of costs and, but the 
ﬁ nal effect of its introduction is not clear: it may reduce the frequency of inappropriate 
caesarean sections, but it may also increase the costs due to complications
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OBJECTIVES: To investigate hospital pharmacists’ perception towards their current 
clinical role in Pakistan’s health care system. METHODS: The study population 
consisted of hospital pharmacists from three cities of Punjab, Pakistan; Islamabad, 
Faisalabad and Lahore. a sample of 116 hospital pharmacists was selected from 
government hospitals from these three cities. RESULTS: At least 77.6% of the hospital 
pharmacists involved in patient counseling in Pakistan. Although they are willing to 
take personal responsibility to resolving any drug related problem but pharmacist (n 
= 98, 84.5%) conveyed that their current role is more focusing towards the record 
keeping of hospital pharmacy. Only (n = 67, 57.8%) of the pharmacist expressed that 
they are involve in making and designing of hospital formulary. In this case signiﬁ cant 
difference was noted with respect to age (p = 0.020) and gender (p = 0.056).As far as 
experience with other health care profession is concern, only (n = 60, 51.7%) of the 
respondents were agreed of having collaborative relationship with other health care 
professional. Moreover only (n = 65, 56.0%) of the hospital pharmacist agreed regard-
ing their suggestion taken into consideration by physician. CONCLUSIONS: The 
ﬁ ndings suggest that the hospital pharmacists in Pakistan do have concerns about their 
present professional role but they are facing signiﬁ cant barriers in terms of increasing 
clinical services. Moreover, pharmacists need to be proactive in collaboration with 
other health care professionals. This paves the way for the concept of pharmaceutical 
care in health care system of Pakistan.
